A comprehensive view of Injectables/Infusions/IV Drips. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Tissue & Hygiene Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

FDA approves Dutch biotech firm UniQure’s Hemgenix injectable to treat hemophilia B, making it the first gene therapy treatment for the disorder; Australian drugmaker CSL has license for the treatment and places list price at US$3.5M
Published: November 23, 2022 by BioPharma Dive
Eli Lilly lists a new clinical trial to study of injectable LY3305677 in participants with obesity or overweight
Published: November 23, 2022 by Contify Life Science News
Novo Nordisk invests 5.4B Danish kroner in expansion of clinical manufacturing facilities in Bagsværd, Denmark; expansion to create additional R&D capacity to manufacture active pharmaceutical ingredients for oral, injectable products
Published: November 22, 2022 by GlobeNewswire Europe
GSK halts US marketing process for Blenrep injectable multiple myeloma treatment after recent disappointing trial data; multiple myeloma is a type of bone marrow cancer
Published: November 22, 2022 by Proactive Investors
FDA approves Provention Bio's Tzield teplizumab-mzwv injectable, the first drug approved to delay onset of stage 3 type 1 diabetes in adults, children 8 years and older; drug carries price of US$193,900 for 14-day treatment
Published: November 21, 2022 by Formulary Watch

Ask us about our Tissue & Hygiene market view

Trending Chart

Interactive chart with headline count